<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30574810</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5762</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Drug development and industrial pharmacy</Title><ISOAbbreviation>Drug Dev Ind Pharm</ISOAbbreviation></Journal><ArticleTitle>The inactivation of the non-enveloped enterovirus 71 (EV71) by a novel disinfectant gel formulation for topical use.</ArticleTitle><Pagination><StartPage>506</StartPage><EndPage>513</EndPage><MedlinePgn>506-513</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/03639045.2018.1562464</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand-foot-mouth disease may cause severe central nervous system complications and even death, that is induced mainly by enterovirus 71 (EV71), which is a non-enveloped virus. Inactivation of the EV71 on hands could effectively inhibit the transmission. However, the inactivations of the EV71 by conventional disinfectants including the alcohols are poor, due to the high stability of the EV71. A novel pyridyl imidazolidinone compound (TJAB1099) was designed to specifically inhibit EV71 replication in vitro. It may potentially be developed as formulations applied on hands for EV71 transmission control.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The stress stability of TJAB1099 was first evaluated after storing in high temperature (60&#x2009;&#xb0;C, RH 10%), high humidity (25&#x2009;&#xb0;C, RH90%), and the high-intensity photolysis (4500&#x2009;Lx &#xb1; 500&#x2009;Lx) for 15&#xa0;days, respectively. A wash-free antimicrobial gel containing the TJAB1099 was developed using the copolymer carrier. The antiviral activity, the acute oral toxicity, and the local irritation of the antimicrobial gel were evaluated accordingly.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The results indicated that the TJAB1099 was stable during the storage in high temperature and humidity. However, a significant change (p&#x2009;&lt;&#x2009;.0001) was detected when TJAB1099 stored in the high-intensity photolysis. The antimicrobial gel containing 1&#x2009;&#x3bc;M TJAB1099 could inhibit EV71 significantly higher than the ethanol (75%) (p&#x2009;&lt;&#x2009;.0001) and commercialized disinfectant products (p&#x2009;&lt;&#x2009;.0001). The results of acute oral toxicity and the local irritation suggest that the TJAB1099 containing antimicrobial gel was not causing skin irritations and acute oral toxicity symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results suggest that the antimicrobial gel containing TJAB1099 was safe and could effectively inhibit EV71 transmission in vitro.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hai-Qiu</ForeName><Initials>HQ</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Xu He (Tianjin) Medical Technology Co., Ltd., The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yong-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shu-Yan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Xu He (Tianjin) Medical Technology Co., Ltd., The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu-Pu</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Chen-Qiang</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Shao-Juan</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun-Wei</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>a Tianjin International Joint Academy of Biomedicine, The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Xu He (Tianjin) Medical Technology Co., Ltd., The Tianjin Economic-Technological Development Area (TEDA) , Tianjin , China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Drug Dev Ind Pharm</MedlineTA><NlmUniqueID>7802620</NlmUniqueID><ISSNLinking>0363-9045</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004202">Disinfectants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005782">Gels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004202" MajorTopicYN="N">Disinfectants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005782" MajorTopicYN="N">Gels</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013242" MajorTopicYN="N">Sterilization</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hand-foot-and-mouth disease</Keyword><Keyword MajorTopicYN="N">antimicrobial gel</Keyword><Keyword MajorTopicYN="N">copolymer</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">formulation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30574810</ArticleId><ArticleId IdType="doi">10.1080/03639045.2018.1562464</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>